Logo-bi
Original Research
Aynur Karadağ Gürel* ORCID, Selçuk Gürel ORCID
BioImpacts. 2022;12(2): 89-105. doi: 10.34172/bi.2022.23467
PMCID: PMC8905584     PMID: 35411297     Scopus ID: 85127154960    
As a result, it suggests that the enriched genes and new pathways emerging as a result of the analysis may help identify the group that responds poorly to treatment and the outcome of the treatment.
Original Article
Rakhshinda Habib* ORCID, Rabia Farhat, Mohsin Wahid, Jahanara Ainuddin
Bioimpacts. 2025;15: 30600 | Published on: 2024 Nov 04. doi: 10.34172/bi.30600
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons